IBOC:NASDAQInternational Bancshares Corporation Analysis
Data as of 2026-06-09 - not real-time
$74.48
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
International Bancshares (IBOC) is trading at $74.48, comfortably above its 20‑day SMA ($72.24) and 50‑day SMA ($71.51), indicating a sustained bullish bias. The RSI sits at 61.8, well below overbought levels, while the MACD line remains above its signal, reinforcing momentum. Valuation metrics are compelling: the trailing P/E of 11.1 is markedly lower than the industry average of 16.6, and the DCF‑derived fair value of $84.9 suggests roughly a 17% upside potential. The dividend yield of 1.95% coupled with a modest payout ratio of 21% underscores dividend sustainability. Risk indicators are moderate, with a beta of 0.71 and 30‑day volatility of 18.5%, and volume trends are increasing, supporting liquidity. A recent insider transaction saw a director sell $720,000 worth of shares, a localized event that is unlikely to shift the broader upside narrative.
Overall, IBOC blends solid fundamentals, attractive valuation, and supportive technicals, positioning it as a potentially rewarding play for investors seeking stable income and capital appreciation in the regional banking sector.
Overall, IBOC blends solid fundamentals, attractive valuation, and supportive technicals, positioning it as a potentially rewarding play for investors seeking stable income and capital appreciation in the regional banking sector.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators (price above SMAs, MACD bullish)
- Support level at $70.28 provides downside cushion
- Director sale is isolated and not material to market cap
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to DCF fair value and industry P/E
- Strong cash position versus debt and low payout ratio
- Consistent dividend yield enhancing total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Stable regional footprint in Texas and Oklahoma
- Sustainable earnings growth and solid ROE (~13.5%)
- Low beta and moderate volatility suggest defensive characteristics
Key Metrics & Analysis
Financial Health
Revenue Growth5.40%
Profit Margin49.85%
P/E Ratio11.1
ROE13.51%
ROA2.52%
P/B Ratio1.4
Op. Cash Flow$471.3M
Industry P/E16.6
Technical Analysis
TrendBullish
RSI61.8
Support$70.28
Resistance$75.68
MA 20$72.24
MA 50$71.51
MA 200$69.54
MACDBullish
VolumeIncreasing
Fear & Greed Index85.95
Valuation
Fair Value$84.91
Target Price$87.00
Upside/Downside16.81%
GradeUndervalued
TypeValue
Dividend Yield1.95%
Risk Assessment
Beta0.71
Volatility18.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.